{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:15:20Z","timestamp":1767665720332},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":9503,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1093\/annonc\/5.suppl_2.s127","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T21:54:55Z","timestamp":1353362095000},"page":"S127-S132","source":"Crossref","is-referenced-by-count":61,"special_numbering":"S2","title":["Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy"],"prefix":"10.1016","volume":"5","author":[{"given":"V.","family":"Zagonel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Babare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Merola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Talamini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lazzarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Monfardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0005","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM199304083281409","article-title":"Treatment of non-Hodgkin\u2019s lymphoma","volume":"328","author":"Armitage","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0010","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.1986.4.3.295","article-title":"Effect of age on therapeutic outcome in advanced diffuse histocytic lymphoma: The Southwest Oncology Group experience","volume":"4","author":"Dixon","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0020","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.1988.6.12.1838","article-title":"The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin\u2019s lymphoma","volume":"6","author":"Vose","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0025","series-title":"The management of non-Hodgkin\u2019s lymphomas in Europe","first-page":"35","article-title":"Management of non-Hodgkin\u2019s lymphomas in elderly patients: Conclusions of the Second Intercity Meeting of the European School of Oncology (ESO), 1987","author":"Zagonel","year":"1990"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0030","first-page":"1991","article-title":"Non-Hodgkin\u2019s lymphoma in the elderly","volume":"66","author":"Carbone","year":"1990","journal-title":"I. Pathologic features at presentation. Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1200\/JCO.1992.10.2.228","article-title":"A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavourable non-Hodgkin\u2019s lymphoma","volume":"10","author":"Tirelli","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1532-5415.1984.tb02020.x","article-title":"Aggressive chemotherapy for diffuse histocytic lymphoma in the elderly: Increased complications of advancing age","volume":"32","author":"Armitage","year":"1984","journal-title":"J Am Geriatr Soc"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0045","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1200\/JCO.1988.6.11.1708","article-title":"Non-Hodgkin\u2019s lymphomas in 137 patients aged 70 years or olden: A retrospective European Organization for Research and Treatment of Cancer Lymphoma Group study","volume":"6","author":"Tirelli","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0959-8049(93)90376-Q","article-title":"Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy","volume":"29","author":"Trillet-Lenoir","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199107183250305","article-title":"Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer (r-met-HuG-CSF)","volume":"325","author":"Crawford","year":"1991","journal-title":"N Eng J Med"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jnci\/85.6.488","article-title":"Decision analysis of hemopoietic growth factor use in patients receiving cancer chemotherapy","volume":"85","author":"Lyman","year":"1993","journal-title":"J Nad Cancer Inst"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0065","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/1097-0142(19860601)57:11<2185::AID-CNCR2820571117>3.0.CO;2-N","article-title":"Non-Hodgkin\u2019s lymphoma in the elderly: A retrospective clinicopathologic study of 56 patients","volume":"57","author":"Carbone","year":"1986","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0277-5379(87)90316-6","article-title":"Non-Hodgkin\u2019s lymphomas in the elderly: Prospective studies with specifically devised chemotherapy regimens in 66 patients","volume":"23","author":"Tirelli","year":"1897","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/07357909009018923","article-title":"Combination chemotherapy specifically devised for elderly patients with unfavourable non-Hodgkin\u2019s lymphoma","volume":"8","author":"Zagonel","year":"1990","journal-title":"Cancer Invest"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/oxfordjournals.annonc.a057979","article-title":"Superiority of second- over first-generation chemotherapy in a randomized trial for stage III\u2013IV intermediate- and high-grade non-Hodgkin\u2019s lymphoma (NHL): The 1980\u20131985 EORTC trial","volume":"2","author":"Carde","year":"1991","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0090","first-page":"135","article-title":"Shortcut and nonparametric methods","volume":"8","author":"Snedecor","year":"1980","journal-title":"In Statistical methods. Ames: Iowa State University Press,"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0095","first-page":"215","article-title":"One-way classifications: Analysis of variance","volume":"12","author":"Snedecor","year":"1980","journal-title":"In Statistical methods. Ames: Iowa State University Press,"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0100","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM198806023182202","article-title":"Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium","volume":"318","author":"Gabrilove","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mpo.2950180202","article-title":"Prognostic factors for patients with diffuse large-cell or immunoblastic non-Hodgkin\u2019s lymphoma pathologic classification project","volume":"18","author":"Simon","year":"1990","journal-title":"Med Ped Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a058068","article-title":"Chronological age is a multifactorial prognostic variable in patients with non-Hodgkin\u2019s lymphoma","volume":"3","author":"Ansell","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood.V62.2.413.413","article-title":"Initial chemotherapy for clinically localized lymphomas of unfavourable histology","volume":"62","author":"Miller","year":"1983","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0120","first-page":"952","article-title":"The hematopoietic micro-environment in the elderly: Defects in IL-1 induced CSF expression in vitro","volume":"17","author":"Lee","year":"1989","journal-title":"Exp Hematol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1532-5415.1992.tb01936.x","article-title":"Recombinant hemopoietic growth factors: Comparative hemopoietic response in younger and older subjects","volume":"40","author":"Shank","year":"1992","journal-title":"J Am Geriatr Soc"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1182\/blood.V63.3.502.502","article-title":"Effect of age on hemotopoiesis in man","volume":"63","author":"Lipschitz","year":"1984","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0268-960X(92)90007-D","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): Receptor biology, signal transduction and neutrophil activation","volume":"6","author":"Rapoport","year":"1992","journal-title":"Blood Rev"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0140","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood.V80.6.1430.1430","article-title":"Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin\u2019s lymphoma: A randomized controlled trial","volume":"80","author":"Pettengell","year":"1992","journal-title":"Blood"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0145","series-title":"Am Soc Clin Oncol Educational Book","first-page":"34","article-title":"The therapeutic utility of G- and GM-CSF in counteracting the bone marrow suppression of chemo- and radiotherapy","author":"Miller","year":"1993"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0150","series-title":"Proceedings of the Satellite Symposium at the Fifth European Conference on Clinical Oncology,","first-page":"14","article-title":"Optimal dose and scheduling of rh-GM-CSF for the abrogation of chemotherapy-induced neutropenia","author":"Morstyn","year":"1989"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0155","first-page":"1","volume":"4","author":"Wallerstein","year":"1990","journal-title":"Hematopoietic growth factors in cancer treatment In Principles and practice of oncology. PPO Updates. Philadelphia: JB Lippincott,"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02354883","article-title":"Cellular and molecular aspects in immune system aging","volume":"37","author":"Doggett","year":"1981","journal-title":"Mol Cell Biochem"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(68)92893-6","article-title":"Reciprocal change with age in antibody to extrinsic antigens","volume":"2","author":"Rowley","year":"1968","journal-title":"Lancet"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0170","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1349-7006.1990.tb02530.x","article-title":"Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer","volume":"81","author":"Eguchi","year":"1990","journal-title":"Jpn J Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0175","first-page":"76","article-title":"Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy for malignant lymphomas","volume":"9","author":"Ogawa","year":"1990","journal-title":"Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0180","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/bjc.1987.295","article-title":"Phase I\/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small-cell lung cancer","volume":"56","author":"Bronchud","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0185","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1200\/JCO.1989.7.10.1554","article-title":"Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy","volume":"7","author":"Morstyn","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_2.S127_bb0190","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/jnci\/85.7.532","article-title":"S, Yancik R Cancer in the elderly: Meeting the challenge of an aging population","volume":"85","author":"Monfardini","year":"1993","journal-title":"J Natl Cancer Inst"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419633909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419633909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/5\/suppl_2\/S127\/6679363\/5-suppl_2-S127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:16:13Z","timestamp":1589537773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419633909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":38,"alternative-id":["S0923753419633909"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/5.suppl_2.s127","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1994]]}}}